Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Gossamer Bio Q3 EPS $(0.21) Misses $(0.18) Estimate, Sales $13.294M

Author: Benzinga Newsdesk | November 05, 2025 04:31pm

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.18) by 16.02 percent. This is a 50 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $13.294 million. This is a 40.23 percent increase over sales of $9.480 million the same period last year.

Posted In: GOSS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist